rs1555085575
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_004064.5(CDKN1B):c.285delC(p.Gly97ValfsTer22) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. P95P) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_004064.5 frameshift
Scores
Clinical Significance
Conservation
Publications
- multiple endocrine neoplasia type 4Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, ClinGen
- multiple endocrine neoplasiaInheritance: AD Classification: STRONG Submitted by: G2P
- hereditary nonpolyposis colon cancerInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_004064.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDKN1B | NM_004064.5 | MANE Select | c.285delC | p.Gly97ValfsTer22 | frameshift | Exon 1 of 3 | NP_004055.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| CDKN1B | ENST00000228872.9 | TSL:1 MANE Select | c.285delC | p.Gly97ValfsTer22 | frameshift | Exon 1 of 3 | ENSP00000228872.4 | ||
| CDKN1B | ENST00000396340.1 | TSL:3 | c.285delC | p.Gly97ValfsTer22 | frameshift | Exon 1 of 2 | ENSP00000379629.1 | ||
| CDKN1B | ENST00000614874.2 | TSL:6 | c.285delC | p.Gly97ValfsTer22 | frameshift | Exon 1 of 2 | ENSP00000507272.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461798Hom.: 0 Cov.: 51 AF XY: 0.00 AC XY: 0AN XY: 727206
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Multiple endocrine neoplasia type 4 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gly97Valfs*22) in the CDKN1B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in CDKN1B are known to be pathogenic (PMID: 17030811, 24819502). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with CDKN1B-related conditions. For these reasons, this variant has been classified as Pathogenic.
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.285delC pathogenic mutation, located in coding exon 1 of the CDKN1B gene, results from a deletion of one nucleotide at nucleotide position 285, causing a translational frameshift with a predicted alternate stop codon (p.G97Vfs*22). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at